東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Breast cancer research and treatment = innovative concepts /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Breast cancer research and treatment/ edited by Ouissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano.
其他題名:	innovative concepts /
其他作者:	Al Jarroudi, Ouissam.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	viii, 368 p. :ill., digital ;24 cm.
內容註:	Antibody-drug conjugates -- Tumor-Infiltrating Lymphocytes as a Surrogate Biomarker for PD-L1 -- Immune checkpoint inhibitors -- Screening programs for breast cancer -- Transversal perspectives of integrative oncology care -- Assessment and response to neoadjuvant treatments -- Precision surgery for the treatment of breast cancer -- A precise approach for radiation therapy of breast cancer -- Fast mimicking diets and other innovative nutritional interventions to treat patients with breast cancer -- Endocrine resistance of breast cancer -- Innovative therapeutic approaches for patients with HER2- positive breast cancer -- Management of patients with breast cancer and brain metastasis -- New concepts in cardio-oncology -- Clinical utility, cost-effectiveness, and budgetary impact of next-generation sequencing in metastatic breast cancer -- ONCOLLEGE-001: The global landscape on the access to cancer medicines for breast cancer.
Contained By:	Springer Nature eBook
標題:	Breast - Cancer -
電子資源:	https://doi.org/10.1007/978-3-031-33602-7
ISBN:	9783031336027

Breast cancer research and treatment = innovative concepts /
Breast cancer research and treatmentinnovative concepts /[electronic resource] :edited by Ouissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano. - Cham :Springer International Publishing :2023. - viii, 368 p. :ill., digital ;24 cm. - Cancer treatment and research,v. 1882509-8497 ;. - Cancer treatment and research ;v. 188..

Antibody-drug conjugates -- Tumor-Infiltrating Lymphocytes as a Surrogate Biomarker for PD-L1 -- Immune checkpoint inhibitors -- Screening programs for breast cancer -- Transversal perspectives of integrative oncology care -- Assessment and response to neoadjuvant treatments -- Precision surgery for the treatment of breast cancer -- A precise approach for radiation therapy of breast cancer -- Fast mimicking diets and other innovative nutritional interventions to treat patients with breast cancer -- Endocrine resistance of breast cancer -- Innovative therapeutic approaches for patients with HER2- positive breast cancer -- Management of patients with breast cancer and brain metastasis -- New concepts in cardio-oncology -- Clinical utility, cost-effectiveness, and budgetary impact of next-generation sequencing in metastatic breast cancer -- ONCOLLEGE-001: The global landscape on the access to cancer medicines for breast cancer.

This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of low income countries of conducting research in the era of precision medicine for cancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.

ISBN: 9783031336027

Standard No.: 10.1007/978-3-031-33602-7doiSubjects--Topical Terms:

792963
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.9944906

Breast cancer research and treatment = innovative concepts /
LDR:03120nmm a2200337 a 4500 001 2390178
003 DE-He213
005 20240104091516.0
006 m d
007 cr nn 008maaau
008 250916s2023 sz s 0 eng d
020 $a 9783031336027 $q (electronic bk.)
020 $a 9783031336010 $q (paper)
024 7 $a 10.1007/978-3-031-33602-7 $2 doi
035 $a 978-3-031-33602-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.9944906 $2 23
090 $a RC280.B8 $b B828 2023
245 0 0 $a Breast cancer research and treatment $h [electronic resource] : $b innovative concepts / $c edited by Ouissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a viii, 368 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer treatment and research, $x 2509-8497 ; $v v. 188
505 0 $a Antibody-drug conjugates -- Tumor-Infiltrating Lymphocytes as a Surrogate Biomarker for PD-L1 -- Immune checkpoint inhibitors -- Screening programs for breast cancer -- Transversal perspectives of integrative oncology care -- Assessment and response to neoadjuvant treatments -- Precision surgery for the treatment of breast cancer -- A precise approach for radiation therapy of breast cancer -- Fast mimicking diets and other innovative nutritional interventions to treat patients with breast cancer -- Endocrine resistance of breast cancer -- Innovative therapeutic approaches for patients with HER2- positive breast cancer -- Management of patients with breast cancer and brain metastasis -- New concepts in cardio-oncology -- Clinical utility, cost-effectiveness, and budgetary impact of next-generation sequencing in metastatic breast cancer -- ONCOLLEGE-001: The global landscape on the access to cancer medicines for breast cancer.
520 $a This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of low income countries of conducting research in the era of precision medicine for cancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
650 0 $a Breast $x Cancer $x Treatment. $3 792963
650 0 $a Breast $x Cancer $x Research. $3 2068036
650 0 $a Oncology. $3 751006
650 0 $a Gynecology. $3 618102
650 2 4 $a Cancer Biology. $3 3594253
700 1 $a Al Jarroudi, Ouissam. $3 3756399
700 1 $a El Bairi, Khalid. $3 3503457
700 1 $a Curigliano, Giuseppe. $3 3756400
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Cancer treatment and research ; $v v. 188. $3 3756401
856 4 0 $u https://doi.org/10.1007/978-3-031-33602-7
950 $a Medicine (SpringerNature-11650)